Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Alleviant Medical announced today that it brought in $90 million to fund the second pivotal trial of its atrial shunt ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Medtronic (NYSE: MDT) says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with hypertension.

Haemonetics announced today that it has completed its previously announced sale of its whole blood assets to GVS S.p.A.

Virtuoso Surgical announced today that it took part in a federal program aiming to bring together surgical robotics and AI.

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its BrainSense adaptive deep brain stimulation ...

[Image courtesy of Biobot] Biobot Surgical announced today that it received CE mark for its Mona Lisa 2.0 surgical robotic ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Butterfly Network announced preliminary findings from a study demonstrating the benefits of point-of-care ultrasound.

Medtronic (NYSE: MDT) announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical.

SS Innovations announced today that surgeons completed the world's first robotic cardiac telesurgeries using its Mantra ...